ArticleFrontiers in oncology2020

Case Report: BAP1 Mutation and RAD21 Amplification as Predictive Biomarkers to PARP Inhibitor in Metastatic Intrahepatic Cholangiocarcinoma.

Francesco Sabbatino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.